Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Martin Murphy


Dr. Martin Murphy is the Co-Founder and serves as Chief Executive Officer & Director at Syncona Investment Management. He is the Chairman of Quell Therapeutics. He serves as Project Manager at Cambridge Consultants. He is a Board Memeber of Achilles Therapeutics and Anaveon. He is the Chairman of Blue Earth Diagnostics.

Primary Investor Type
Angel (individual)
Primary Office
  • 2nd Floor
  • 8 Bloomsbury Street
  • London WC1B 3SR
  • England, United Kingdom

Martin Murphy Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
0000000 00000000 15-Sep-2015 00000 00000 00.000 Biotechnology Generating Revenue 000000 000000 00.0
To view this investor’s complete investment and acquisition history, request access »
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Martin Murphy’s full profile, request a free trial.

Martin Murphy Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000000 00000000 01-Jun-2018 000000000000000000 Completed
  • 0000000
To view this investor’s complete exits history, request access »

Martin Murphy Team (1)

Name Title Deals Funds Boards Office Contact
Martin Murphy Ph.D Angel Investor 00 0 0 London, United Kingdom